G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2011
12/08/2011	WO2011153300A2 Monoclonal antibodies detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid in plants
12/08/2011	WO2011153287A2 Materials and methods for diagnosing and predicting the course of prostate cancer
12/08/2011	WO2011153271A1 Predicting plaque composition and phenotype in coronary arteries via hdl-subclass analysis, and methods related thereto
12/08/2011	WO2011153236A1 Purified compositions of cardiovascular progenitor cells
12/08/2011	WO2011153234A2 Methods of inhibiting alu rna and therapeutic uses thereof
12/08/2011	WO2011153211A1 Apparatus for measurement of spinning forces relating to molecules
12/08/2011	WO2011152983A2 Fluid flow contour control using flow resistance
12/08/2011	WO2011152883A2 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics
12/08/2011	WO2011152793A1 Rapid multi-line hepatitis c virus assay
12/08/2011	WO2011152779A1 Method for decision support in allergy diagnosis
12/08/2011	WO2011152731A1 Method for determining efficacy of therapy and determining presence or risk of disease
12/08/2011	WO2011152580A1 Device for preventing reuse of lancet
12/08/2011	WO2011152554A1 Method for producing tumor cell
12/08/2011	WO2011152519A1 Detection method
12/08/2011	WO2011152503A1 Treatment drug for autoimmune diseases and allergic diseases
12/08/2011	WO2011152272A1 Method of determining the risk of adverse effects of irinotecan, and kit therefore
12/08/2011	WO2011152238A1 Urine analysis method, device thereof, program used in urine analysis method, and storage medium thereof
12/08/2011	WO2011152236A1 Gel particle measurement device
12/08/2011	WO2011152193A1 Urine analyzer
12/08/2011	WO2011152098A1 Developing solution for immunochromatography method, and measurement method using same
12/08/2011	WO2011152071A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof
12/08/2011	WO2011152067A1 Device for detecting biomolecule and method for detecting biomolecule
12/08/2011	WO2011152064A1 Surface plasmon resonance fluorescence analysis device and surface plasmon resonance fluorescence analysis method
12/08/2011	WO2011152043A1 Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in mammalian organisms
12/08/2011	WO2011152012A1 Method for testing the severity of an illness
12/08/2011	WO2011151964A1 Method for detecting antigens
12/08/2011	WO2011151804A1 A fluidic interfacing system and assembly
12/08/2011	WO2011151783A1 Method for assaying lower respiratory tract infection or inflammation
12/08/2011	WO2011151746A1 System and method for determining the asphaltene content of crude oil
12/08/2011	WO2011151743A1 Apparatus and method for estimating bilirubin concentration using refractometry
12/08/2011	WO2011151658A1 Anti-ageing agents
12/08/2011	WO2011151597A1 Method of detecting rupture of membranes
12/08/2011	WO2011151595A1 Method for revealing a toxic substance in a sample
12/08/2011	WO2011151467A2 Water distribution system comprising a device for measuring the value of at least one parameter representative of the water quality
12/08/2011	WO2011151350A1 System for determining an analyte in a water sample
12/08/2011	WO2011151344A1 Method of in-vitro evaluation of the physiological state of a gastric mucous membrane and kit for carrying out such an evaluation
12/08/2011	WO2011151335A1 High-throughput method for determining the presence of papillomavirus-neutralizing antibodies in a sample
12/08/2011	WO2011151287A1 Naphthocyanines for use as contrast agents
12/08/2011	WO2011151252A2 Means and methods for diagnosing pancreatic cancer in a subject
12/08/2011	WO2011151250A1 Method and device for optical examination
12/08/2011	WO2011151148A2 Method of toxicological evaluation, method of toxicological screening and associated system
12/08/2011	WO2011151076A2 MONOCLONAL ANTIBODIES TARGETING Αβ OLIGOMERS
12/08/2011	WO2011151027A1 Method for preparing a sample for chromatographic separation processes and systems for carrying out a sample preparation
12/08/2011	WO2011151026A1 System for carrying out a sample preparation
12/08/2011	WO2011150994A2 Serum and tissue biomarkers of human hcc
12/08/2011	WO2011150974A1 Biomarkers for lung neuroendocrine tumors
12/08/2011	WO2011150752A1 Rapid detection tool and kit for premature rupture of fetal membrane taking icam-1 as detection index
12/08/2011	WO2011150675A1 Biochip comprising multiple microchannels
12/08/2011	WO2011150633A1 Detection system and humidity detection method for detecting volatile organic compound
12/08/2011	WO2011150542A1 Process for labeling antibody with copper oxide nanoparticle, kit and use thereof
12/08/2011	WO2011150541A1 Visual detection method for antigen/antibody reaction, kit and applications thereof
12/08/2011	WO2011150517A2 Biomarker for diagnosis and treatment of colorectal cancer
12/08/2011	WO2011150516A1 Diagnostic, screening and therapeutic applications of ocab-based tools
12/08/2011	WO2011150509A2 Methods of diagnosing asthma
12/08/2011	WO2011150475A1 Optical mapping of genomic dna
12/08/2011	WO2011150472A1 A method of quantifying soil carbon
12/08/2011	WO2011150453A1 Diagnostic, prognostic and therapeutic use of a long non-coding rna
12/08/2011	WO2011130742A3 Diagnostic evaluation of antibody responses to commonly recognized prostate cancer-associated antigens
12/08/2011	WO2011130691A3 Gna11 and gnaq exon 4 mutations in melanoma
12/08/2011	WO2011127150A3 Gene-expression profiling with reduced numbers of transcript measurements
12/08/2011	WO2011121453A3 Methods and compositions for treating or ameliorating cancer using gemcitabine-5'-elaidate
12/08/2011	WO2011113895A3 Characterization and validation of inhibitors and ligands of dipeptidyl aminopeptidase iv (dp iv)
12/08/2011	WO2011103666A8 Modulation of cytokine-induced chronic inflammatory responses
12/08/2011	WO2011094555A3 Rotationally actuated magnetic bead trap and mixer
12/08/2011	WO2011091270A3 Biomarkers for lung disease monitoring
12/08/2011	WO2011091037A3 Rapid pathogen diagnostic device and method
12/08/2011	WO2011085176A3 Fret-based method for the determination of protein phosphatase and kinase activity
12/08/2011	WO2011084703A3 Enzyme assays on a droplet actuator
12/08/2011	WO2011081437A3 Sample analysis cartridge and sample analysis cartridge reader
12/08/2011	WO2011073905A8 Novel tumor markers
12/08/2011	WO2011073901A8 Novel tumor markers
12/08/2011	WO2011062634A3 Monoclonal antibodies and diagnostic uses thereof
12/08/2011	WO2011041350A3 Xenotropic mulv-related virus (xmrv) compositions and methods of use
12/08/2011	WO2011027310A8 Novel tumor markers
12/08/2011	WO2010131193A8 Phosphodiesterase 9a as prostate cancer marker
12/08/2011	WO2010087743A8 The use of basigin-1 in stem cell and cancer applications
12/08/2011	WO2009099896A9 Thermal denaturation screening assay to identify candidate compounds for prevention and treatment of parkinson's disease
12/08/2011	WO2008127617A9 Method and apparatus for analyzing a sample such as a biodiesel fuel sample
12/08/2011	US20110302674 Methods and Compositions for the Improvement of Plant Tolerance to Environmental Stresses
12/08/2011	US20110302670 Polynucleotides and methods for the improvement of plants
12/08/2011	US20110302665 Non-human mammals with t or b cells having predefined specificity
12/08/2011	US20110301930 Method for determining gene knockouts
12/08/2011	US20110301535 Microfluidic control systems
12/08/2011	US20110301442 Diagnostic analyte collection device based on flexible polymers with biological surface modification and microfluidic functionality
12/08/2011	US20110301329 Process for the Purification of Recombinant Albumin
12/08/2011	US20110301227 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms
12/08/2011	US20110301194 Method for Determining Treatment Efficacy
12/08/2011	US20110301191 Methods of treatment using selective 5-ht2a inverse agonists
12/08/2011	US20110301186 Use of haptoglobin genotyping in diagnosis and treatment of cardiovascular disease
12/08/2011	US20110301160 Inhibitors of P38 and Methods of Using the Same
12/08/2011	US20110301145 Pyridazinones, method of making, and method of use thereof
12/08/2011	US20110301127 Methods of reducing microbial resistance to drugs
12/08/2011	US20110301110 TRIM33 (TIF1gamma) AS A NEW DIAGNOSTIC MARKER OF CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
12/08/2011	US20110301103 Methods of Treatment
12/08/2011	US20110301095 Methods and compositions for assessing and treating metastasis, metastatic cancer, and potential for metastasis
12/08/2011	US20110301093 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
12/08/2011	US20110301065 Identifying antigen clusters for monitoring a global state of an immune system
12/08/2011	US20110301056 Nectin-4 for target genes of cancer therapy and diagnosis
12/08/2011	US20110301048 Diagnosis and prognosis of breast cancer patients
12/08/2011	US20110301047 Sensing device for sensing a fluid

1 ... 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 ... 3937